PRENTISS SMITH & CO INC - Immunovaccine Inc ownership

Quarter-by-quarter ownership
PRENTISS SMITH & CO INC ownership history of Immunovaccine Inc
ValueSharesWeighting
Q4 2017$206,000
+98.1%
110,0000.0%0.10%
+85.2%
Q2 2017$104,000
+1055.6%
110,000
+1000.0%
0.05%
+980.0%
Q1 2017$9,000
-83.6%
10,000
-90.9%
0.01%
-85.3%
Q4 2016$55,000
-9.8%
110,0000.0%0.03%0.0%
Q3 2016$61,000
+7.0%
110,000
-8.3%
0.03%
+6.2%
Q2 2016$57,000
+42.5%
120,0000.0%0.03%
+39.1%
Q1 2016$40,000
-34.4%
120,0000.0%0.02%
-28.1%
Q4 2015$61,000
+454.5%
120,000
+500.0%
0.03%
+433.3%
Q3 2015$11,000
-87.8%
20,000
-83.3%
0.01%
-86.4%
Q2 2015$90,000
+26.8%
120,0000.0%0.04%
+29.4%
Q1 2015$71,000
+491.7%
120,000
+500.0%
0.03%
+466.7%
Q4 2014$12,000
-25.0%
20,0000.0%0.01%
-25.0%
Q3 2014$16,000
+23.1%
20,000
-1.8%
0.01%
+14.3%
Q2 2014$13,000
-27.8%
20,3600.0%0.01%
-30.0%
Q1 2014$18,000
+350.0%
20,360
+96.5%
0.01%
+400.0%
Q4 2013$4,000
+300.0%
10,360
+2777.8%
0.00%
+100.0%
Q3 2013$1,0000.0%3600.0%0.00%0.0%
Q2 2013$1,0003600.00%
Other shareholders

There were no reported owners of Immunovaccine Inc in Q3 2023.

NameSharesValueWeighting ↓
View complete list of Immunovaccine Inc shareholders